3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
5
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Conditions
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Small Cell Lung Carcinoma
1
Osteosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Hodgkin Disease
1
Interventions
Cisplatin
2
avelumab
1
Paclitaxel
1
Ifosfamide
1
Everolimus
1
Disulfiram
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Neoplasms, Germ Cell and Embryonal
×
Ifosfamide
×
Clear all
NCT02414685
2020-08-07
TIP
National Cancer Institute, Slovakia
Phase 2
Completed
19 enrolled